Summary
Edwards Lifesciences Corporation (EW) filed an 8-K on March 8, 2006, to report a reclassification of $14 million from its 2005 operating cash flows. This reclassification is a non-cash accounting adjustment and does not impact the company's overall financial performance or total cash generated during the fiscal year 2005. The purpose of this filing is to provide transparency regarding the specific components of its cash flow statement and to ensure accurate financial reporting. While the reclassification itself does not represent new operational results or a change in the company's underlying business, it is important for investors to understand such adjustments. Investors should refer to the press release (Exhibit 99.1) for detailed information on how this reclassification affects the presentation of cash flows, particularly concerning operating activities. This information is crucial for a comprehensive understanding of the company's financial statements.
Key Highlights
- 1Edwards Lifesciences reclassified $14 million from its 2005 operating cash flows.
- 2The reclassification is a non-cash accounting adjustment.
- 3This adjustment does not change the total cash generated by the company in 2005.
- 4The company filed a Form 8-K on March 8, 2006, to disclose this information.
- 5The press release announcing the reclassification is attached as Exhibit 99.1.
- 6The CFO, Thomas M. Abate, signed the filing, indicating executive oversight.